Potent hepatoprotective effect in CCl4-induced hepatic injury in mice of phloroacetophenone from Myrcia multiflora by Ferreira, Eduardo Antonio et al.
Potent hepatoprotective effect in
CCl4-induced hepatic injury in mice of
phloroacetophenone from Myrcia
multiﬂora
Eduardo Antonio Ferreira
1, Eliana Fortes Gris
1,
Karina Bettega Felipe
1, Joa ˜o Francisco Gomes Correia
1,
Eduardo Cargnin-Ferreira
2, Danilo Wilhelm Filho
3 and
Rozangela Curi Pedrosa
1*
1Department of Biochemistry, Federal University of Santa Catarina, Floriano ´polis, SC, Brazil;
2Department of Cell Biology, Embryology, and Genetics, Federal University of Santa Catarina,
Floriano ´polis, SC, Brazil;
3Department of Ecology and Zoology, Federal University of Santa Catarina,
Floriano ´polis, SC, Brazil
Background: This study investigated the hepatoprotective effect and antioxidant properties of phloroaceto-
phenone (2?,4?,6?-trihydroxyacetophenone   THA), an acetophenone derived from the plant Myrcia
multiflora.
Material & Method: The free radical scavenging activity in vitro and induction of oxidative hepatic damage by
carbon tetrachloride (CCl4) (0.5 ml/kg, i.p.) were tested in male Swiss mice (2595 g).
Results: This compound exhibited in vitro antioxidant effects on FeCl2 ascorbate-induced lipid peroxidation
(LPO) in mouse liver homogenate, scavenging hydroxyl and superoxide radicals, and 2,2-diphenyl-1-
picrylhydrazyl. The in vivo assays showed that THA significantly (pB0.01) prevented the increases of hepatic
LPO as measured by the levels of thiobarbituric acid-reactive substances, mitochondrial swelling. It also
protected hepatocytes against protein carbonylation and oxidative DNA damage. Consistent with these
observations, THA pre-treatment normalized the activities of antioxidant enzymes, such as catalase,
glutathione peroxidase, and superoxide dismutase, and increased the levels of reduced glutathione (GSH)
in CCl4-treated mice. In addition, THA treatment significantly prevented the elevation of serum enzymatic
activities of alanine amino transferase, aspartate amino transferase, and lactate dehydrogenase, as well as
histological alterations induced by CCl4. Silymarin (SIL) (24 mg/kg), a known hepatoprotective drug used for
comparison, led to a significant decrease (pB0.01) in activities of theses enzymes in way very similar to that
observed in pre-treatment with THA.
Conclusion: These results suggest that the protective effects are due to reduction of oxidative damage induced
by CCl4 resulting from the antioxidant properties of THA.
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R
eactive oxygen species (ROS) are causative
factors of degenerative diseases, including some
hepatopathies (1). The overproduction of ROS
and therefore oxidative stress can be initiated by avariety
of factors, including exposure to xenobiotics, such as
acetaminophen and carbon tetrachloride (CCl4) (2). CCl4
has been extensively used to study liver injury induced by
ROS in the mouse model, which is closely analogous to
hepatotoxicity in humans. The hepatotoxic effect of CCl4
is thought to be initiated as a result of its reductive
dehalogenation by cytochrome P450 2E1 to the highly
reactive trichloromethyl radical (
+
CCl3), which is subse-
quently converted into a trichloromethyl peroxyl radical
(
+
OOCCl3) in the presence of oxygen (3). Removal of
hydrogen atoms from unsaturated fatty acids by such
radicals generates carbon-centered lipid radicals. These
lipid radicals quickly add molecular oxygen to form lipid
peroxyl radicals, thereby initiating the process of lipid
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vengers, these peroxyl radicals in turn abstract hydrogen
atoms from other lipid molecules, thereby propagating
the process of LPO (4). Also,
+
CCl3 can react with
sulfhydryl groups, such as reduced glutathione (GSH)
and protein thiols, which eventually leads to abnormal
protein function, membrane LPO and, consequently,
damage to mitochondria and nuclei, leading to impaired
physiological functions of hepatocytes, and finally, to cell
necrosis (5).
In this sense, the antioxidant action plays an important
role in protecting against CCl4-induced liver injury.
Protectiveeffectsofvariousnaturalandsyntheticproducts
against hepatotoxicity have been reported (6 8). Phenolic
compounds or polyphenols, which consist of secondary
vegetal metabolites, constitute a wide and complex array
of phytochemicals that exhibit antioxidant action (9).
Among the phenolic compounds, some acetophenones
possess several biological properties (10). It has been
reported by Mathiesen and collaborators (11) that
phloroacetophenone (2?,4?,6?-trihydroxyacetophenone  
THA; Fig. 1) exercises its antioxidant activity in vitro by
scavenging 2,2-diphenyl-1-picrylhydrazyl (DPPH), but no
further investigations were carried out. THA is the
aglyconepartofaglycosidefromMyrciamultiflora(family
Myrtaceae), a plant popularly known as ‘insulin plant’
and used for diabetes in traditional medicine in South
America. The literature cites several sources for obtaining
phloroacetophenone derivatives, but the free form of
acylphloroglucinol is rare (12 14). Isolated flavanone
and flavonol glucosides have been reported to inhibit
aldose reductase and a-glucosidase activities and to
possess a potential for hypoglycemic activity in alloxan-
induced diabetic animals (15, 16). But only studies that
describe the antioxidant effect and hepatoprotector of
THA are available.
Here, we investigated both the in vitro and in vivo
antioxidant activity and the potential protective effects
of THA in CCl4-induced hepatotoxicity in mice. The
protective activity of THA was compared with that of
Silymarin (SIL), a natural antioxidant that has been used
in clinical practice for the treatment of toxic liver disease
(17). This study was carried out taking into consideration
that THA possesses a beneficial activity as an antioxidant
and hepatoprotective agent, although the mechanism for
the activity remains to be elucidated.
Materials and methods
Chemicals
All chemicals were of the highest commercially available
purity. THA monohydrate was from Fluka. All other
chemicals were from Sigma-Aldrich Co.
Plant material and isolation of phloracetophenone
glucoside
The leaves of cultivated M. multiflora were obtained from
Albano Ferreira Martins, Ltd., Sa ˜o Paulo, Brazil. The
dried leaves of M. multiflora were subjected to the
methods of extraction and isolation of phloracetophe-
none glucoside according to Suksamraran and collabora-
tors (18). The compound was isolated and identified by
preparative TLC and analyzed by
1H NMR. IR showed
that data were consistent with those reported for the
4,6-dihydroxy-2-O-(b-D-glucopyranosyl) acetophenone.
Indeed, by the acidic hydrolysis of the compound
mentioned above, it is possible to prepare the THA.
To obtain phloroacetophenone, 4,6-dihydroxy-2-O-
(b-D-glucopyranosyl) acetophenone (200 mg) was treated
with 3 N HCl in methanol (200 ml) at a reflux
temperature of 1008C for 30 min (18 20). After neutra-
lization by careful addition of 20% aqueous NaHCO3
and elimination of methanol under vacuum and con-
trolled temperature, the phloracetophenone was ex-
tracted with CH2Cl2, followed by the evaporation of
solvent and recrystallization with boiling water. This
yielded crystals of colorless needles that were submitted
to
1H NMR, IR, and TLC analyses with a synthetic
standard of THA monohydrate. Analytical TLC was
carried out on 0.2-mm plates of silica gel 60 F254 (Merck,
Darmstadt). For separation and identification of com-
pounds, the following mobile phases (a, b) and spray
reagent (c) were used: (a) AcOet H2CO2 HOAc H20
(500:5:5:2); (b) CHCl3 (CH3)2CO H2CO2 (150:33:17),
and (c) vanillin/H2SO4 (10% vanillin in a 2:1 mixture of
99.5% ethanol and concentrated H2SO4), followed by
heating for color development.
In vitro antioxidant activity
The free radical scavenging activityof THAwas evaluated
using the 2-diphenyl-1-picryl-hydrazyl-hydrate (DPPH)
radical scavenger method and measured at 518 nm (21).
Superoxide anion (O
+ 
2 ) was measured according to
Robak and Gryglewski (22), using its generation through
xanthine/xanthine oxidase and detected by nitro blue
tetrazolium (NBT) reduction at 560 nm. The hydroxyl
radical (
+
OH) was generated by the deoxyribose
OH
O
HO
OH
Fig. 1. Chemical structure of 2?,4?,6?-trihydroxyacetophenone
(phloroacetophenone, THA).
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was indirectly detected through the pink chromophore
measuredat 532 nm (23). LPO was assayed using the TBA
method, as described by Chen and Tappel (24). THA
antioxidant activities in vitro were evaluated in triplicates
intherange0.5to500mg/mlandtheresultswereexpressed
as IC50, which was the concentration (in mg/ml) of THA
required to inhibit the generation rates of radicals by 50%.
SIL, a mixture of four flavonolignans that possesses a
recognized ROS scavenger activity as well as a hepatopro-
tective effect, was used as the antioxidant standard (17).
Animals
Male Swiss mice, supplied by the local Bioterio Central
of the Federal University of Santa Catarina and weighing
2595 g, were housed under controlled conditions (12-h
light dark cycle, 22928C, 60% air humidity), and had
free access to standard laboratory chow and water. All
animal procedures were conducted in accordance with
legal requirements appropriate to the species (Guiding
Principles for the Care and Use of Laboratory Animals,
NIH publication #85.23, revised in 1985) and with the
approval of the local Ethics Committee.
Hepatoprotective activity
Hepatotoxicity was induced by CCl4 (0.5 ml/kg body
weight in olive oil, injected intraperitoneally) according
to the method described by Carbonari et al. (7). THAwas
preliminarily evaluated at 3, 6, and 12 mg/kg body weight
and the dose of 6 mg/kg was selected because it was the
lowest dose that could normalize the hepatic enzymes
aspartate amino transferase (AST), alanine amino trans-
ferase (ALT), and lactate dehydrogenase (LDH). Mice
were randomly divided into five groups (n 6 each
group) and administered orally by gavage during 7 days
as follows:
(1) Group I: Control group, treated with vehicle (saline)
daily for 7 days.
(2) Group II: Treated with vehicle (saline) daily for 7
days followed by CCl4 on day 7.
(3) Group III: Treated with THA (6 mg/kg) daily for 7
days.
(4) Group IV: Treated with THA (6 mg/kg) daily for
7 days followed by CCl4 on day 7.
(5) Group V: Treated with SIL (24 mg/kg) daily for 7
days.
(6) Group VI: Treated with SIL (24 mg/kg) daily for
7 days followed by CCl4 on day 7.
Approximately 24 h after the i.p. administration of CCl4,
blood sample was collected and serum was separated to
evaluate the biochemical markers of hepatic injury. After
that, animals were euthanized by cervical dislocation and
the livers were immediately excised, weighed, and kept on
ice for analysis of biomarkers of oxidative damage, assay
of antioxidant enzymes, mitochondrial swelling, and
histological analyses.
Determination of biochemical markers of hepatic
injury
Blood was placed at room temperature for 1 h and then
centrifuged at 1,000g for 10 min to obtain serum. The
enzymatic activities of AST, ALT, and LDH were assayed
spectrophotometrically according to Reitman and
Frankel (25), Bergmeyer (26), and Allain et al. (27),
using a commercial kit (LABTEST, Diagnostica S.A.,
Minas Gerais, Brazil).
Oxidative damage biomarkers
Peroxidation of hepatic tissue lipids, in vivo, was mea-
sured by the method of Okawa et al. (28). The amount of
thiobarbituric acid-reactive substances (TBARS) was
expressed as nmoles of TBARS formed per mg of protein
and using a molar coefficient (o) of 153 mmol/l per cm.
Oxidative damage of proteins was quantified as carbonyl
protein content according to the method of Levine et al.
(29). This method is based on spectrophotometric
detection of the end product of the reaction of 2,4-
dinitrophenylhydrazine with protein carbonyl to form
protein hydrazones detected at 370 nm, and the results
were expressed as nmoles of carbonyl group per mg of
protein, using o 22 mmol/l per cm. Liver GSH levels
were measured by a spectrophotometric method (30) in
acid hepatic homogenates combined with disodium
hydrogen phosphate and DTNB solution, and the yellow
chromophore formed was quantified at 412 nm using a
molar coefficient (o) of 14.1 mmol/l per cm. The results
were expressed in mmol per mg of protein.
Detection of DNA damage
The extent of DNA fragmentation was assessed by the
alkaline Comet assay proposed by Singh et al. (31). Liver
samples (100 mg) were homogenized in 1,000 ml phos-
phate-buffered saline (PBS) (1:9) and 10 ml of this
solution was added to 70 ml of 0.75% low-melting point
agarose. The cell/agarose mixture was added to a fully
frosted microscope slide coated with a layer of 300 mlo f
normal-melting agarose (1%). The slides were immersed
into a cold and freshly made lysis solution [2.5 mM NaCl,
100 mM EDTA, 1% Triton X-100, 10% dimethyl
sulfoxide (DMSO) and 10 mM Tris, pH 10] for a
minimum of 2 h. Subsequently, the slides were incubated
in freshly prepared alkaline buffer (300 mM NaOH
and 1.0 mM EDTA, pH 13) for 30 min. DNA was
subjected to electrophoresis for 30 min at 280 mA and
25 V, and then neutralized with 0.4 M Tris, pH 7.5.
Finally, DNAwas stained with ethidium bromide (2.0 mg/
ml). Images of 100 randomly selected cells (50 cells from
each of two replicate slides) were analyzed from each
Hepatoprotective and antioxidant properties of THA
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were measured in arbitrary units. A DNA damage index
(DI) was compiled according to tail size, from unda-
maged (0) to maximally damaged (400), resulting in a
single DNA damage score for each animal, and conse-
quently, for each group studied. Thus, the DI of each
group ranged from 0 (completely undamaged) to 400
(maximum damage).
Antioxidant enzymes
Catalase (CAT) activity was determined by measuring at
240 nm the decrease of H2O2 in a freshly prepared 10 mM
hydrogen peroxide solution; the results are expressed in
mmol/min per mg protein and o 40 mmol/l per cm (32).
Superoxide dismutase (SOD) activity in homogenates was
determined by measuring the inhibition of the rate of
autocatalytic adrenochrome formation and expressed in
U SOD/mg protein (33). Glutathione peroxidase (GPx)
activity was quantified by a coupled assay with glu-
tathione reductase (GR) catalyzed oxidation of NADPH.
Measurements were made at 340 nm and expressed in
mmol/min per mg protein (34). Protein was measured by
the method of Lowry et al. (35) using bovine serum
albumin as standard.
Determination of mitochondrial swelling
Mitochondria were prepared from mouse liver according
to the method of Aprille et al. (36). In brief, livers of mice
were excised and homogenized in an isolation buffer
(225 mM d-mannitol, 75 mM sucrose, 0.05 mM EDTA,
10 mM Tris HCl pH 7.4) at 48C. The homogenates were
centrifuged at 600g for 5 min and supernatants were
centrifuged at 8,800g for 10 min. The pellet was washed
twice with the same buffer. Protein concentration was
determined by using Coomassie Brilliant Blue (37).
Mitochondrial swelling was assessed by measuring
the absorbance of their suspension at 540 nm (38). Liver
mitochondria isolated from each group of mice were
dissolved at 0.5 mg protein per ml in 3 ml of the assay
buffer (125 mM sucrose, 50 mM KCl, 2 mM KH2PO4,
10 mM HEPES, 5 mM succinate). To the assay buffer was
added 50 mmol/l of Ca
2  to initiate mitochondrial
swelling and the absorbance (A) at 0.5, 1, 2, 3, 4, 5,
and 6 min was measured. The rate of mitochondrial
swelling was calculated by using following formula:
 DAbs:Test   DAbs:CCl4
DAbs:Control   DAbs:CCl4

 100%;
where D Abs:0 min Abs:6 min
Histological analyses
The hepatic duct was chosen (adjacent to liver) to
standardize the histological analyses and to avoid mis-
interpretations. Samples of the same liver lobes (8 15
 3 4 mm ( for all treatments were fixed in 10% of
formalin buffered with 0.1 M phosphate (pH 7.2). After
fixation, samples were washed in tap water for 4 h and
dehydrated through an increasing ethanol series, cleared,
and embedded in 56 60% paraffin. Sections were cut at
5-mm thickness, stained with Cason’s trichromic staining,
and mounted in Eukit medium (39). Histological sections
were photographed under a light microscope with a
digital image capture system (Olympus, model Dx 41).
Statistical analysis
Data were expressed as means9SD. Statistical analysis
was performed to compare treated groups with the
respective control groups using one-sample Kolmogorov-
Smirnov analysis of normality and two-way analysis of
variance (ANOVA), followed by the Duncan’s multiple
range test where appropriate. Values of pB0.01 were
considered statistically significant.
Results
In vitro antioxidant activity
A marked difference in DPPH radical scavenging capa-
city was found: the isomeric mix of flavonolignans SIL
showed a higher DPPH scavenging capacity than THA
(Table 1). Accordingly, SIL inhibited the generation of
superoxide anion radicals to a greater extent than THA,
but it is important to note that SIL concentration was
about four-fold higher than that of THA. Curiously, no
significant difference between SIL and THAwas detected
regarding both
+
OH scavenging capacity and protection
against membrane LPO (Table 1).
Biochemical markers of hepatic injury
After 12 h since administration of CCl4 to mice, the levels
of markers, such as ALT, AST, and LDH activities, were
high in serum sample when compared with controls
Table 1. In vitro antioxidant activity of THA and Silymarin
measured by scavenging of DPPH, O
+ 
2 and
+
OH radicals,
and protection against lipid peroxidation (LPO) (levels
of thiobarbituric acid reactive substances) in hepatic
homogenates
IC50 (mg/ml)
b
Compounds DPPH O
+ 
2
+
OH LPO
THA 50.990.5
a 66.590.8
a 5.791.3 7.790.7
Silymarin 13.990.7 45.491.5 7.690.8 10.190.5
Note: All values are expressed as means9SD (n 6).
aStatistically significant compared to Silymarin (pB0.01).
bIC50: inhibitory concentration at 50% was obtained by linear
regression.
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restored levels of these hepatic markers, except for LDH
activity.
Oxidative damage biomarkers and DNA
fragmentation
Pre-treatment of mice with THA or SIL had a remark-
able antioxidant effect and prevented the LPO induced
by CCl4 (82.7% and 83.3%, respectively) (Fig. 2A). In
accordance with the results related to LPO, protein
oxidation quantified as carbonyl protein content also
showed a significant increase after CCl4 treatment
(51.9%), which was significantly decreased by THA
or SIL pre-treatment (35.8% and 31.2%, respectively)
(Fig. 2B). In addition, fluorescence microscopy revealed
that CCl4 caused remarkable DNA fragmentation (DI 
110.293.3) in hepatocyte homogenates when compared
to the control group (DI 49.091.0). On the other hand,
DNA fragmentation in mice pre-treated with THA or
SIL (DI 51.092.0 and 45.094.0) was similar to that in
control mice (Fig. 2C).
Glutathione (GSH) content and antioxidant enzymes
When administration of CCl4 to the mice resulted in
approximately 60% depletion of hepatic GSH levels
compared with controls (Table 3). Pre-treatment with
THA or SIL was effective in protecting hepatocytes
against such depletion. On the other hand, CCl4 treat-
ment resulted in a significant (pB0.01) decrease of the
hepatic enzymes CAT, SOD, and GPx when compared
with the negative control group. THA or SIL pre-
treatments prevented such decreases, which were within
normal limits (Table 3).
Mitochondrial swelling
Calcium-induced remarkable mitochondrial swelling
in normal mice, which was greatly attenuated in mice
pre-treated with CCl4 (46.9%) (Fig. 3), suggesting a
decline in the sensitivity of mitochondria to swelling
due to high calcium content. However, THA or SIL
blocked such attenuation with inhibitory rates of 49.5%
and 47.7%, respectively.
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Fig. 2. Effect of THA (6 mg/kg body weight) or Silymarin
(24 mg/kg body weight) on hepatic lipid peroxidation (A),
protein carbonylation (B), and DNA damage Index (C)
in CCl4-induced hepatotoxicity in mice. Bars represent
means9SD, n 6.
aSigniﬁcantly different from CCl4-treated
mice (pB0.01).
Table 2. Effects of THA and Silymarin on CCl4-induced
liver damage in mice
Serum Enzymes
Groups ALT (U/l) AST (U/l) LDH (U/l)
Control group 29.293.5
a 9.191.1
a 237.2938.3
a
CCl4 91.091.5 38.491.6 541.4941.2
THA 35.292.4
a 13.191.4
a 284.9928.3
a,b
THA CCl4 30.992.3
a 10.591.0
a 272.4933.7
a
Silymarin 35.592.1
a 15.791.2
a 295.1929.3
a
Silymarin CCl4 32.191.1
a 12.790.8
a 289.6930.5
a,b
Note: ALT, alanine aminotransferase; AST, aspartate amino-
transferase; LDH, lactate dehydrogenase. Values are mean9SD
(n 6).
apB0.01 compared to CCl4-treated mice.
bCompared to control group.
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Histological analyses revealed that in terms of morphol-
ogy, livers subjected to all treatments generally showed
normal structural integrity. The stromal and the par-
enchymal portions presented structural characteristics of
healthy liver of mice. Intact hepatocytes plates were
observed in fairly radial position in relation to the
centrolobular vein with reticular fibers present on both
sides. Plenty of capillary sinusoids of normal caliber and
non-congestion were also observed. Hepatocytes were
large and polyhedral, with round nuclei, abundant
heterochromatin and nucleoli quite evident, all of which
are characteristic of normal cells. However, when using
Cason’s staining, which can reveal distinct substrates with
different colors, the CCl4 group (Fig. 4G) showed higher
variation in color with two distinct populations of
hepatocytes (separated by dashed lines). These cells
exhibited a variety of substrates in the cytoplasm (as
revealed by different staining), indicating that although
initial morphological changes are not evident, there are
indications of changes in hepatocyte metabolism. When
the histological preparations are observed in a smaller
magnification, the number of hepatocytes with different
colors (and therefore with different metabolic activities)
form groups quite limited under CCl4 treatment not clear
(Fig. 4C, dashed lines). When comparing the other
groups, the appearance in color (and thus in cell
physiology) is very similar to each other (Fig. 4A E,
dotted lines), showing that the hepatoprotective treat-
ments with THA (Fig. 4D) and SIL (Fig. 4E) were very
effective against the hepatotoxic effects of CCl4.
Discussion
We demonstrate that THA has a concentration-dependent
scavenging capacity for the DPPH radical higher than
that of SIL, which is attributable to its hydrogen-donating
Table 3. Effects of THA and Silymarin on GSH levels and antioxidant enzyme activities (CAT, SOD, and GPx) in livers of
treated mice and of control mice
Groups GSH (mmol/mg protein) CAT (mmol/min/mg protein) SOD (U SOD/mg protein) GPx (mmol/min/mg protein)
Control group 34.1490.12
a 8.3190.29
a 10.0890.26
a 33.3592.00
a
CCl4 24.6590.14 5.3390.46 6.6490.13 23.1491.80
THA 30.7290.18
a 7.8790.31
a 8.4590.45
a 34.6891.10
a
THA CCl4 31.1490.14
a 8.1790.27
a 9.1890.65
a 29.9291.30
a
Silymarin 32.0690.22
a 7.7090.33
a 10.2790.39
a 32.7991.42
a
Silymarin CCl4 29.8290.15
a 7.4390.15
a 14.0190.73
a 31.9791.50
a
Note: GSH, reduced glutathione; CAT, catalase; SOD, superoxide dismutase; GPx, glutathione peroxidase. Values are mean9SD (n 6).
apB0.01 compared to the CCl4-treated mice.
Fig. 3. Effect of THA (6 mg/kg body weight, by gavage) or Silymarin (24 mg/kg body weight, by gavage) on Ca
2 -induced
mitochondrial swelling. Bars represent means9SD for, n 6.
aSigniﬁcantly different from CCl4-treated mice (pB0.01).
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characteristics of absorption that decreases significantly
on exposure of proton radical scavengers (40).
In the present study, THA or SIL were able to scavenge
O
+ 
2 in a concentration-dependent manner, measured by
the xanthine/xanthine oxidase and NBT assays (Table 1).
Although the superoxide anion (O
+ 
2 ) is a relatively weak
oxidant, it reacts to form more potent ROS, such as the
hydroxyl radical (
+
OH), which initiate LPO processes
(41). Furthermore, superoxide anion (O
+ 
2 ) is also
indirectly initiate the LPO as a result of H2O2 formation,
creating precursors of
+
OH (41). Taking this into
account, the results suggest that the antioxidant activity
of THA is also related to its ability to scavenge the
superoxide anion (O
+ 
2 ):
In the LPO assay,
+
OH was scavenged by co-incubation
of mouse liver homogenate with different concentrations
of THA or SIL, and both phenolic compounds showed
substantial and similar protection against membrane LPO
(Table 1). Furthermore, the evidence of
+
OH scavenging
Fig. 4. Histological analyses of liver in control mice (A), mice treated with THA (B), mice treated with CCl4 (C), mice
pre-treated with THA followed by CCl4 (D), and mice pre-treated with Silymarin followed by CCl4 (E). Liver tissue was stained
with trichromic Cason’s staining (100 , bar 100 mm). Photomicrographs Fand G show histocytological details of normal and
abnormal livers, respectively (Cason’s staining 1000 , bar 10 mm). Dashed lines separate the number of hepatocytes with
different staining and arrows showed the nucleus and reticular ﬁbers.
Hepatoprotective and antioxidant properties of THA
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system, which displayed an IC50 close to that of SIL,
thereby explaining such a strong protection against LPO.
This property probably relies on the presence of phenolic
hydroxyls at the ortho and para positions (11). An early
study that used this system to assess the biological activity
of natural plant-derived biomolecules reported that
molecules that can inhibit deoxyribose degradation are
those that can chelate iron ions and render them inactive
or poorly active for the Fenton reaction (42). In summary,
the in vitro results suggest that THA, which effectively
scavenges several ROS, behaves in a way similar to SIL.
The broad activity range related to THA suggests that
multiple and synergistic mechanisms are probably respon-
sible for the antioxidant activity of this acetophenone-
derived substance.
CCl4 is known to cause hepatic damage manifested in
marked elevation in serum levels of LDH and amino
transferase enzymes (AST and ALT), especially ALT,
which is considered the primary and specific marker of
liver injury (43). Accordingly, our results also showed a
significant increase in the activities of AST, ALT, and
LDH, thereby confirming the hepatocellular damage in
CCl4-treated mice. A similar profile was observed by
Hewawasam and collaborators (44) in adult Swiss
mice treated with CCl4 (0.5 ml/kg in olive oil). After
pre-treatment with THA, the activities of these enzymes
were decreased to values similar to those of controls
(Table 2). THA could also prevent the CCl4-induced
increase in hepatic TBARS levels, suggesting that THA
inhibits LPO and its propagation reactions (Fig. 2A). In
addition, the histological analyses revealed typical
toxicological effects on hepatocytes promoted by CCl4,
as already described in the literature (45, 46). THA alone
increased LDH levels in relation to controls but this
enhancement was significantly lower than that observed
in CCl4 treatment.
CCl4 causes marked toxicity by increasing the liver
LPO, as detected by enhanced levels of hepatic TBARS
(47, 48). As already mentioned, CCl4 hepatotoxicity
depends on the reductive dehalogenation of CCl4 cata-
lyzed by CYP450 in the hepatic endoplasmic reticulum,
leading to the generation of an unstable complex of
trichloromethyl peroxy radicals (CCl3
+
), which is re-
ported to be a highly reactive species (5). This free
radical attacks membrane lipids, causing their peroxida-
tion, and may also covalently bind to lipids and proteins,
thereby initiating deleterious processes that ultimately
leads to cell damage. THA may afford cell protection by
impairing CCl4-mediated LPO, thus preventing the gen-
eration of free radical derivatives, if the ameliorated
TBARS levels and mitochondrial sensitivity to calcium
are taken into consideration (Fig. 2A).
Besides the finding that CCl4 increased LPO, it also
depleted intracellular GSH levels, indicating that GSH
loss might result from the detoxification of CCl4 by GSH
conjugation. In addition, the previous enhancement of
carbonyl protein contents was significantly prevented in
mice treated with THA or SIL, suggesting a further
antioxidant protection against protein oxidation. There-
fore, these combined results strongly suggest that acet-
ophenone acts as an antioxidant.
The histopathological analysis provided complemen-
tary evidence that pre-treatment with THA or SIL
attenuated the cytoplasmatic changes in mouse liver
induced by CCl4 administration. The hepatocyte plate
of CCl4-treated mice resulted in cytophysiological
changes shown by Cason’s trichrome staining, revealing
different colors in the cytoplasm (Fig. 4). This might have
been due to the formation of highly reactive radicals
associated with the oxidative threat induced by CCl4.
Cellular accumulation of lipid hydroperoxides can cause
cytotoxicity associated with peroxidation of membrane
phospholipids by lipid hydroperoxides, the basis for a
related cellular damage (41). The cytophysiological
changes coincided with increased levels of LPO
(Fig. 2A), protein oxidation (Fig. 2B), and DNA
fragmentation (Fig. 2C), while the administration of
THA or SIL prevented such biochemical and histological
alterations induced by CCl4. This effect could be
attributable to the antioxidant activity of these two
compounds, which significantly attenuated the oxidative
threat and led to restoration of normal physiological
functions.
In addition, the antioxidant enzymes CAT and GPx in
mice pre-treated with THA or SIL and then treated with
CCl4 had activities similar to those of controls (Table 3).
Treatment of mice with CCl4 concurrently induces
processes in acute injury and also in regeneration, in
which injury events are predominantly expressed at early
stages, although this regeneration process is latent (49). A
possible reason why CAT and GPx activities were
augmented after treatment with THA or SIL in the
presence of CCl4 is the capacity of these compounds to
counteract CCl4-induced massive ROS production (41).
Therefore, we speculate here that THA plays a role
during the early stages in CCl4-induced liver injury,
decreasing LPO and protein carbonylation and, conse-
quently, improving cellular antioxidant status, thereby
preventing ALT, AST, and LDH leakage from liver.
The activity of GPx, an important antioxidant enzyme
that takes part in the enzymatic neutralization of free
radicals, was significantly decreased by CCl4 treatment
and normalized in mice pre-treated with THA or SIL.
This result strongly suggests that CCl4, probably through
its conversion to CCl
+
3; the active metabolite produced in
the liver after oral administration, inhibits the activity of
GPx. In accordance with the response found in GPx,
CAT activity also showed decreased values after CCl4
treatment, and again the pre-treatment with THA was
Eduardo Antonio Ferreira et al.
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diminished GSH content together with the persistent
enhancement of TBARS levels found in livers of mice
treated with CCl4, these combined results suggest that
this organ was facing a severe oxidative insult. It also
strongly suggests that this process was reversed after
THA treatment because THA possesses some antioxidant
properties that can guarantee GSH maintenance prob-
ably through ROS neutralization.
In contrast to the toxic activation of CCl4 via P450 2E1
biotransformation process, the detoxification pathway
also involves GSH conjugation of the
+
CCl3, a P450 2E1-
mediated CCl4 metabolite (50). A previous study on the
mechanism of CCl4-induced hepatotoxicity showed that
GSH plays a key role in detoxifying the toxic metabolites
of CCl4 and that liver necrosis begins when GSH stores
are markedly depleted (4). GSH levels are largely
mediated by the activity of glutathione-S-transferase,
generating adducts with the toxic metabolites of CCl4,
and it has been suggested that one of the main causes of
CCl4-induced liver injury is protein and LPO caused by
its free radical derivatives (4). As already mentioned, the
present results showed that pre-treatment with THA or
SIL significantly inhibited LPO, protein carbonylation,
and DNA damage and that it also inhibited CCl4-
induced hepatic GSH depletion.
ROS inflict damage on several cellular structures and
functional components, including DNA, even under
physiological conditions (41). The present study showed
a 52% enhancement of DNA fragmentation in mice
exposed to CCl4 compared to the control group. How-
ever, DNA damage in liver was decreased in animals pre-
treated with THA, suggesting that either the system of
enzymatic repair was induced and/or an increase in
antioxidant defenses in cell nuclei took place.
In conclusion, both the in vitro and the in vivo results
indicate that THA can protect mouse liver from injury
induced by CCl4 probably through its ROS scavenging
ability. Nevertheless, further research must be carried out
to verify the capacity of THA to block P450-mediated
CCl4 bioactivation and also to elucidate the mechanisms
regarding the hepatoprotective effect of THA at the
molecular level.
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